These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5494840)

  • 21. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
    Kanematsu M; Semelka RC; Leonardou P; Mastropasqua M; Lee JK
    J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rare complications of hepatic neoplasias; hemoperitoneum due to the rupture of a primary hepatic carcinoma; neoplastic thrombosis of the inferior vena cava in cancer-cirrhosis].
    Duchini L
    Arch De Vecchi Anat Patol; 1967 Nov; 50(1):511-36. PubMed ID: 5616078
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prognostically significant factors of complications after liver resection].
    Iusifoglu NB
    Vestn Khir Im I I Grek; 1999; 158(4):97-100. PubMed ID: 10533240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary hemochromatosis].
    Kinová S; Boca M; Buzgová D; Galbavý S; Stvrtina S
    Vnitr Lek; 2002 Nov; 48(11):1082-6. PubMed ID: 12577461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and morphological study of hepatocellular carcinoma associated with liver cirrhosis.
    Antón MD; Serra MA; Del Olmo J; Rodrigo JM
    Rev Esp Enferm Dig; 1997 Aug; 89(8):599-610. PubMed ID: 9299919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of CCl4-induced liver fibrosis by Piper longum Linn.?
    Christina AJ; Saraswathy GR; Robert SJ; Kothai R; Chidambaranathan N; Nalini G; Therasal RL
    Phytomedicine; 2006 Feb; 13(3):196-8. PubMed ID: 16428029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [With primary liver carcinoma-associated cholestasis].
    Varga L; Jakabovits A; Brittig F
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():120-1. PubMed ID: 7483692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
    Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
    Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.
    Yeh CN; Chen MF; Lee WC; Jeng LB
    J Surg Oncol; 2002 Dec; 81(4):195-202. PubMed ID: 12451624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The prognostic value of serochemical cholestasis parameters in liver cirrhosis].
    Rink C; Haerting J; Nilius R
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():67-70. PubMed ID: 7483719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HBsAg positive cirrhosis of the liver with hepatocellular carcinoma, malignant gastric lymphoma and clear-cell renal adenoma].
    Kubancok J; Zuffa M; Krónerová M
    Cesk Gastroenterol Vyz; 1982 Sep; 36(6):327-32. PubMed ID: 6291789
    [No Abstract]   [Full Text] [Related]  

  • 35. Morphology and function of the liver in the course of surgical treatment of choledocholithiasis.
    Sokolnicki J; Tyśper Z
    Pol Med J; 1967; 6(2):422-8. PubMed ID: 6030651
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepatectomy under liver normothermic ischemia in primary liver cancer patients associated with cirrhosis].
    Wang C; Shao Y
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):374-6. PubMed ID: 8697980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Introduction of medical records. IV. Record of internal medicine].
    Lyon Med; 1971 Feb; 225(4):329-32. PubMed ID: 5088598
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of oxyphenbutazone on liver function in man.
    Pentikäinen LA; Mustala OO
    Ann Clin Res; 1972 Oct; 4(5):296-9. PubMed ID: 4644451
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chromodiagnosis of the liver: interpretation of the elimination curve of indocyanine green dye (Wofaverdin)].
    Seifert A; Ehrke D; Balzer H
    Z Gesamte Inn Med; 1968 Sep; 23(17):527-31. PubMed ID: 5728034
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetes mellitus in chronic active hepatitis and cirrhosis.
    Kingston ME; Ali MA; Atiyeh M; Donnelly RJ
    Gastroenterology; 1984 Sep; 87(3):688-94. PubMed ID: 6086443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.